CDER?s Division of Post-Marketing Evaluation for Quality Assessment

July 1, 2006

Special Issues

Special Issues, Special Issues-07-01-2006, Volume 0, Issue 0

The new Division of Post Marketing Evaluation in the Office of New Drug Quality Assessment has implemented an improved system for managing the submission and review processes for post approval chemistry, manufacturing, and controls change supplements.